家用美容仪监管变革
Search documents
即将“持证上岗”,家用美容仪如何守护“颜值安全”?
新华网财经· 2026-03-30 12:10
Core Viewpoint - The regulation of home beauty devices, particularly radiofrequency (RF) beauty devices, is transitioning from a consumer electronics category to a third-class medical device category, effective April 1, 2026, which will significantly impact the industry landscape and market dynamics [1][12]. Group 1: Regulatory Changes - The National Medical Products Administration (NMPA) has mandated that RF beauty devices must be registered as third-class medical devices, with unregistered products prohibited from production, import, and sales [1][12]. - The transition period for compliance has been extended to April 1, 2026, allowing companies time to adapt to the new regulations [1][12]. - As of now, only 13 brands have successfully registered their RF skin treatment devices, indicating a high barrier to entry due to stringent registration requirements [6][8]. Group 2: Market Dynamics - The market for RF beauty devices has seen a significant shift, with a reduction in the number of RF products available on e-commerce platforms and a rise in non-RF products like microcurrent devices and LED masks [2][5]. - The search interest for "RF beauty devices" has been declining since 2023, with projections indicating a steep drop in interest post-2025 [2][4]. - The sales figures for RF beauty devices surged from approximately 480 million yuan during the 2019 Double 11 shopping festival to nearly 1.8 billion yuan in 2020, showcasing rapid growth prior to regulatory changes [10]. Group 3: Industry Transformation - The tightening regulations are forcing the industry to shift from rapid expansion to compliance and technological innovation, with companies focusing on product safety and efficacy [13][18]. - Brands are increasingly investing in R&D to enhance product safety and effectiveness, moving towards a model that emphasizes clinical validation and compliance with medical device standards [18][19]. - The competitive landscape is expected to consolidate, with smaller brands likely to be eliminated as the market becomes more concentrated around established players who can meet regulatory requirements [13][18].